Neu Differentiation Factor Inhibits EGF Binding

A MODEL FOR TRANS-REGULATION WITHIN THE ErbB FAMILY OF RECEPTOR TYROSINE KINASES (*)

  1. Devarajan Karunagaran(1),
  2. Eldad Tzahar(1),
  3. Naili Liu(2),
  4. Duanzhi Wen(2) and
  5. Yosef Yarden(1)(§)
  1. From the (1) Department of Chemical Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel and the
  2. (2) Amgen Center, Thousand Oaks, California 91320
  1. § Recipient of a Career Research Development Award from The Israel Cancer Research Fund. To whom correspondence should be addressed. Tel.: 972-8-343974; Fax: 972-8-344141.

Abstract

Neu differentiation factor (NDF, or heregulin) and epidermal growth factor (EGF) are structurally related proteins that bind to distinct members of the ErbB family of receptor tyrosine kinases. Here we show that NDF inhibits EGF binding in a cell type-specific manner. The inhibitory effect is distinct from previously characterized mechanisms that involve protein kinase C and receptor internalization because it occurred at 4°C and displayed reversibility. The extent of inhibition correlated with both receptor saturation and affinity of different NDF isoforms, and it was abolished upon overexpression of either EGF receptor or ErbB-2. Binding kinetics and equilibrium analyses indicated that NDF reduced the affinity, rather than the number, of EGF receptors, through an acceleration of the rate of ligand dissociation and deceleration of the association rate. On the basis of co-immunoprecipitation of EGF and NDF receptors, we attribute the inhibitory effect to the formation of receptor heterodimers. According to this model, EGF binding to NDF-occupied heterodimers is partially blocked. This model of negative trans-regulation within the ErbB family is relevant to other subgroups of receptor tyrosine kinases and may have physiological implications.

Footnotes

  • * This work was supported by National Institutes of Health Grant CA51712 and The Wolfson Foundation administered by The Israel Academy of Sciences and Humanities. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    EGF

    epidermal growth factor

    BS3

    bis(sulfosuccinimidyl) suberate

    NDF

    Neu differentiation factor

    PBS

    phosphate-buffered saline

    PKC

    protein kinase C

    TPA

    12- O-tetradecanoyl phorbol 13-acetate.

« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement